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BBB restricts the permeation of most
drugs to the central nervous system
(CNS).
Despite the ability of a therapeutic
molecule to achieve the
therapeutic effect, its in vivo
medical application is not met.
The systemic administration of the
drugs is often challenged by a well-
versed biological impediment: the
blood–brain barrier (BBB).
BBB…
 Although the BBB is crucial
for maintaining brain health
against harmful and toxic
agents that exist in blood, it
also blocks the penetrance
of many drugs.
 It is also the main reason why
treatments for cancer that
work elsewhere in the body
fail routinely when directed
at the brain.
Schematic representation of BBB
BBB…
 The passage of molecules across
the BBB relies primarily on their
structure, surface properties,
and chemical composition.
 Only small molecular weight
drugs (<400–500 Da) and
lipophilic in nature can reach
into the brain.
 Traversing the BBB is a particular
challenge for the large, lipid-
insoluble biological drugs.
BBB…
Over 98% of small-molecule drugs and nearly 100% of large-
molecule drugs such as recombinant proteins and
monoclonal antibodies cannot enter the brain.
A 33% of the total new drugs approved by FDA in 2019 were
biologic drugs: antibody-drug conjugates, an antisense





























NANOPARTICLE DELIVERY TO THE BRAIN
 Nanoparticles loaded with
drugs (small molecules or
macromolecules) have
been intensively studied for
the treatment of brain
diseases with various
successful rates in animal
models.
 To cross the BBB, the surface
of NPs has been crafted
with various kinds of
molecules to recognize the
receptors and transporters
expressed on BBB.
Nanoparticle delivery to the brain…
Highly positive NPs were found
to cross BBB.
Cell penetrating peptides and
positively charged albumin
proteins were often used to




transcytosis is another way







 It is well known that BBB communicates
with the outer surface and obtains its
nutrients by means of a highly
regulated pathway, i.e. endocytosis.
Such endocytic pathways include
fluid-phase endocytosis, receptor
mediated endocytosis and adsorptive
endocytosis.
Receptor mediated and adsorptive
mediated endocytosis is the most






 High expression level of iron-transferrin
receptors on brain endothelium, as
opposed to peripheral endothelium.
 transferrin (Tf) functionalized fluorescein-
loaded magnetic NPs were found located
in the dendrites, synapse of neurons,
cytoplasm and axons, indicating that they
can efficiently cross the intact BBB through
TfR (Yan et al., 2013).
 Since in physiological conditions, majority of
TfR are saturated due to endogenous
proteins, the use of mAbs, such as OX26,
8D3, T7 peptide, MYBE/4C1 and R17217, are
suggested
Receptor mediated transcytosis





 Apolipoprotein E (apoE) is responsible for
transporting several nutrients into the blood.
 Polysorbate-80 coated
poly(butylcyanoacrylate) (PBCA) NPs binds
to apoE of blood plasma and interacts with
LDL receptor on cerebral endothelial cells,
serving as a drug delivery system.
 Two-to-twelve-fold increased uptake and
decreased side effects of rivastigmine and
temozolomide (TMZ) loaded polysorbate-80
NPs were reported for the treatment of AD
and brain tumor, respectively (Tian et al.,
2011; Wilson et al., 2008).
 Another most explored receptor mediated transcytosis
via LDL receptors is angiopep-2 based ligand,
 It is present not only on BBB but also on brain cancer
cells and neurons with Aβ peptide (Ulery et al., 2000).
 Thus, NPs functionalized with angiopep-2 can act as a
specific ligand for LDL receptor related protein (LRP) and
accomplish dual targeting i.e.,
 first crossing BBB and thereafter







D-glucose transporter proteins are
among the most abundant nutrient
transporters present in brain micro
vessels and glioma cells.
Modification of poly(ethylene
glycol)−poly(trimethylene
carbonate) (PEG−PTMC) NPs by 2-
deoxy-D-glucose served as a
potential dual drug targeting
delivery system and resulted in
increased uptake of paclitaxel by
glioma cells (Jiang et al., 2014).
Insulin receptor 
mediated transcytosis
 In an in vivo study,
intravenous administration
of human serum albumin
(HAS) NPs covalently










 The major barrier for nanoparticulate delivery systems.
 If not especially designed to escape from the MPS 
uptake, intravenously administered NPs are rapidly 
cleared from the blood stream (blood half-lives are 
generally in minutes) and mostly accumulate in liver 
and spleen.
 It is generally admitted that opsonization, the first step 
for MPS recognition, is favored by hydrophobic 
surfaces.
 In contrast, hydrophilic coating sterically stabilizes NPs 
and reduces opsonization and MPS uptake.
 To avoid the MPS uptake, size below 100 nm is 
preferred.
MPS (Mononulcear Phagocytic System)
CONCLUSION
 In conclusion, with the emerging of
biological drugs as effective
therapeutic molecules, new
advanced delivery systems are
needed to facilitate the BBB
penetration for effective clinical
outcome.
Nanomedicine designed to target
specific receptors in the BBB has the
potential to cross the BBB and
deliver the cargo inside the brain.

